Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity, is a young entrepreneur who founded Biotricity after working in technology and finance and has a background in computer engineering. Today, he discusses their suite of devices and software for real time remote cardiac monitoring and cardiac-oriented telehealth. Bioflux ® is Biotricity’s core product which is a comprehensive mobile cardiac telemetry (MCT) solution encompassing a device, software, and 24/7 monitoring that integrates seamlessly into cardiologists’ existing systems. This allows physicians to see more patients, perform more procedures, and identify which patients need more time and attention.
Author: healthprofessionalradio
Woebot Health – Survey on Attitudes, Beliefs and Views on Mental Health Technology
Dr. Alison Darcy, President and Founder of Woebot Health discusses key findings of their survey “A Paradigm Shift: Consumer Attitudes Toward Mental Health Technology in 2021” She talks about the state of mental health in America and the future of mental health technology.
2021 EADV – New Janssen Data Shows Improvement For PsO Patients Being Treated with TREMFYA (guselkumab)
Dr. Lloyd Miller, MD, PhD, Vice President, Immunodermatology Disease Area Leader at Janssen, discusses new data presented at the 2021 European Academy of Dermatology Venereology Congress (EADV) showing TREMFYA provided durable complete and almost complete skin clearance responses and was well-tolerated with low risk of infection and low rates of anti-drug antibodies in psoriasis (PsO) through up to five years. The patient population studied included PsO patients who switched to TREMFYA from adalimumab. Lloyd talks about what these results mean for patients and healthcare providers.
City of Hope – Couples Coping with Cancer Program
Courtney Bitz, LCSW, MSW, director of Clinical Social Work and Spiritual Care in the Department of Supportive Care Medicine at City of Hope, a comprehensive cancer center near Los Angeles, discusses the Couple’s Coping with Cancer Together program. She is joined by Gayle Whittemore, a breast cancer patient at City of Hope who, with her wife, raised $200,000 and collaborated with City of Hope to start a supportive care program where patients and their loved ones can learn how to go through a cancer diagnosis together. The program guides caregivers on how they could provide support and also receive the support they need so that the relationship remains strong. This program is one of the only programs of its kind and is offered as part of the normal continuum of care provided to patients and families at City of Hope. It is tailored to the unique needs of English and Spanish-speaking couples regardless of sexual orientation or relationship status. Since its inception, Couple’s Coping with Cancer Together at City of Hope has helped nearly 2,300 couples navigate a cancer diagnosis.
Shoreline Biosciences – (iPSC)-Derived Allogeneic Natural Killer (NK) and Macrophage Products
Dr. Kleanthis Xanthopoulos, co-founder, Chairman and CEO of Shoreline Biosciences, discusses the development of genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer (NK) and macrophage products that are intelligently designed for greater specificity, potency and persistence, overcoming the limitations of early cell therapies, for use in oncology and regenerative medicine.
One Doctor’s Work in Social Advocacy
Lisa Johnson-Pratt, MD, Senior Vice President, Ionis Pharmaceuticals, discusses her involvement in causes related to people of color, STEM (Science, Technology, Engineering, Mathematics), and women/girls advocacy. She is a board member of Young People in Recovery and creator of Life After Abuse.
How Mobile Technology is Being Used to Treat Nashville’s Homeless Population
Dr. Peter Cathcart, internal medicine specialist in Nashville, Tennessee discusses his experience using the NextGen ® Mobile app on his phone to access homeless patients’ medical records, prescription lists, appointments and detailed care plans from previous providers.
Encouraging the use of COVID-19 Antibody Therapy
Dr. Elizabeth Nghiem, infectious disease specialist at the ETN Medical Infusion Center in Orange County, CA discusses REGEN-COV, COVID-19 monoclonal antibody therapy for both treatment and post-exposure prevention in people who are at high risk of progression to severe disease, including those with underlying conditions. She talks about the need for more awareness among providers and shares her experience administering this therapy.
The Synthesis Effect
Dr. John McGrail, a Clinical Hypnotherapist and Self Improvement Expert discusses his book, The Synthesis Effect that aims to help people create health, wellness, personal change quickly and profoundly.
Dispelling Myths and Misinformation – Emergency Physicians Separate Fact from Fiction About COVID-19 & the Vaccines
Dr. Jessica Solis-McCarthy, MD, FACEP, emergency medicine physician at UT Health San Antonio and University Hospital and spokesperson for the American College of Emergency Physicians (ACEP), discusses misconceptions about getting the COVID-19 vaccine and addresses the most common concerns she has encountered from those hesitant to receive the shot.